|
C16ORF72 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.828190E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.832400E-01 |
| Normal-vs-Stage2 |
1.913370E-01 |
| Normal-vs-Stage3 |
7.027000E-04 |
| Normal-vs-Stage4 |
1.93845999999498E-05 |
| Stage1-vs-Stage2 |
1.509760E-01 |
| Stage1-vs-Stage3 |
3.208700E-04 |
| Stage1-vs-Stage4 |
3.02990000000669E-06 |
| Stage2-vs-Stage3 |
2.988200E-01 |
| Stage2-vs-Stage4 |
1.105820E-01 |
| Stage3-vs-Stage4 |
3.892600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.182000E-02 |
| Normal-vs-AfricanAmerican |
3.227900E-02 |
| Normal-vs-Asian |
9.382000E-01 |
| Caucasian-vs-AfricanAmerican |
5.276600E-01 |
| Caucasian-vs-Asian |
5.315600E-01 |
| AfricanAmerican-vs-Asian |
3.375000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.662600E-03 |
| Normal-vs-Female |
3.348000E-01 |
| Male-vs-Female |
6.515700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.000390E-01 |
| Normal-vs-Age(41-60Yrs) |
2.233200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.598000E-03 |
| Normal-vs-Age(81-100Yrs) |
8.268000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.694600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.441800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.147000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.434620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.667800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.402600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.252640E-01 |
| Normal-vs-Grade 2 |
9.712400E-01 |
| Normal-vs-Grade 3 |
4.216400E-04 |
| Normal-vs-Grade 4 |
1.90070999999126E-05 |
| Grade 1-vs-Grade 2 |
1.268810E-01 |
| Grade 1-vs-Grade 3 |
1.218790E-03 |
| Grade 1-vs-Grade 4 |
1.793410E-04 |
| Grade 2-vs-Grade 3 |
1.818490E-04 |
| Grade 2-vs-Grade 4 |
4.76439999996803E-06 |
| Grade 3-vs-Grade 4 |
8.527800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.069000E-01 |
| Normal-vs-ccB subtype |
2.641300E-04 |
| ccA subtype-vs-ccB subtype |
3.70570000018944E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.999600E-02 |
| Normal-vs-N1 |
4.252100E-02 |
| N0-vs-N1 |
1.484990E-01 |
|
|
